Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

SELL
$13.2 - $17.76 $59,994 - $80,719
-4,545 Reduced 13.04%
30,321 $539 Million
Q4 2023

Feb 14, 2024

BUY
$6.52 - $20.32 $227,326 - $708,477
34,866 New
34,866 $655 Million

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $1.57B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Susquehanna Portfolio Strategies, LLC Portfolio

Follow Susquehanna Portfolio Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Portfolio Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Portfolio Strategies, LLC with notifications on news.